Preliminary Program June 26

Time

08:00-09:00

Hall 1

Industry Session 3: AstraZeneca

Hall 2

Time

09:00-10:30

Hall 1

Session 5: Cardio-Diabetes 1

Chairs: Christian Herder (Düsseldorf, Germany), Maria Grandoch (Düsseldorf, Germany)

Malte Kelm (Düsseldorf, Germany)
Myocardial infarction and type 2 diabetes

Eberhard Standl (Munich, Germany)
Heart failure in type 2 diabetes: diagnose early – treat preventively

Nikolaus Marx (Aachen, Germany)
CKM – cardio-kidney-metabolic syndrome – Update 2026

Manfredi Rizzo (Palermo, Italy)
Managing the cardiometabolic continuum: a consensus from Europe East and South

Hall 2

Session 6: Young Investigator Session 1

Chairs: Ilze Konrade (Riga, Latvia), Christian Herder (Düsseldorf, Germany)

Alba Sulaj (Heidelberg, Germany)
Targeting metabolism with fasting interventions to alleviate diabetic complications

Adrienn Menyhárt (Budapest, Hungary)
Weekly and seasonal blood glucose fluctuation based on a large database

Viviana Maggio (Palermo, Italy)
Cardiometabolic effects of dual GIP/GLP-1 RAs in people with obesity and diabetes

Djurdja Rafailovic (Belgrade, Serbia)
The role of glucose lowering vs weight reduction in prevention of CVD in type 2 diabetes

Time

11:00-12:30

Hall 1

Session 7: Diabetic Neuropathy and Retinopathy

Chairs: Péter Kempler (Budapest, Hungary), Alexander Strom (Düsseldorf, Germany)

Gidon Bönhof (Düsseldorf, Germany)
New approaches to screen and diagnose diabetic neuropathy

Zoltan Kender (Heidelberg, Germany)
Painful diabetic neuropathy: Current management and future directions

Anna Körei (Budapest, Hungary)
Osteoporosis and diabetic neuropathy

Rainer Guthoff (Düsseldorf, Germany)
Diabetic retinopathy: predictor for diabetic neuropathy?

Hall 2

Session 8: Nutrition, Lifestyle & Prevention

Chairs: Jan Skrha (Prague, Czechia), Tsvetalina Tankova (Sofia, Bulgaria)

Sabrina Schlesinger (Düsseldorf, Germany)
Plant-based diets for diabetes prevention and management

Georgia Xourafa (Düsseldorf, Germany)
The role of dietary fat in the prevention of diabetes

Ilze Konrade (Riga, Latvia)
Type 1 diabetes and celiac disease: clinical considerations

Dario Rahelic (Zagreb, Croatia)
Weight variability as a cardiovascular risk factor?

Time

12:30-13:30

Hall 1

Hall 2

Poster Session (all posters)

Time

13:30-15:00

Hall 1

Session 9: Precision Diabetology

Chairs: Erifili Hatziagelaki (Athens, Greece), Oliver Kuß (Düsseldorf)

Robert Wagner (Düsseldorf, Germany)
Precision medicine in prediabetes

Emma Ahlqvist (Lund, Sweden)
Early determinants and long-term outcomes of diabetes subtypes

Lukasz Szczerbinski (Bialystok, Poland; Boston, USA)
Pharmacogenetics of diabetes and obesity therapies

Julia Szendrödi (Heidelberg, Germany)
Sex-specific aspects of metabolic flexibility

Hall 2

Session 10: Diabetic Kidney Disease

Chairs: Jaroslawna Meister (Düsseldorf, Germany), Manfredi Rizzo (Palermo, Italy)

Nebojsa Lalic (Belgrade, Serbia)
Cardiorenal complications in type 1 diabetes: mechanisms, early markers and outcomes

Boris Mankovsky (Kyiv, Ukraine)
Association of diabetic kidney disease and cardiovascular diseases in type 2 diabetes

Karin Jandeleit-Dahm (Melbourne, Australia; Düsseldorf, Germany)
NOX5 as a novel biomarker in the CKM syndrome

Bogdan Timar (Timisoara, Romania)
The future of diabetic chronic kidney disease pharmacotherapy

Time

16:30-17:30

Hall 1

Session 11: New avenues in diabetes research

Chairs: Nebojsa Lalic (Belgrade, Serbia), Mohamed Elrayess (Doha, Qatar)

Iuliana Popescu (Lexington, USA)
Endogenous pathways of beta-cell regeneration in diabetes

Nikolaos Papanas (Alexandroupolis, Greece)
Diabetic hand

Oana-Patricia Zaharia (Düsseldorf, Germany)
Early detection of complications in diabetes subtypes

Hall 2

Session 12: Cardio-Diabetes 2

Chairs: Katarina Lalic (Belgrade, Serbia), Kálmán Bódis (Düsseldorf, Germany)

Maria Grandoch (Düsseldorf, Germany)
Bone marrow niche remodeling during prediabetes and diabetes progression

Norbert Gerdes (Düsseldorf, Germany)
Reversing cellular senescence to restore cardiovascular functionality in metabolic disease

Thomas Stulnig (Vienna, Austria)
Emerging lipid lowering drugs

Time

17:30-18:00

Hall 1

Evening lecture

Christos Mantzoros (Boston, USA)
Publishing with impact: Lessons from the editor’s desk

Hall 2

Time

18:00-19:00

Hall 1

General Assembly

Hall 2